Pharmafile Logo
Pharmafocus logo
Advanced Search
greek_parliament

Investigation of kickbacks in Greece sputters to halt

May 21, 2018
Sales and Marketing Greece, Novartis, biotech, drugs, pharma, pharmaceutical

Greek parliament has decided against investigating allegations of bribery, involving Novartis and numerous high-level former politicians. The case has dominated …

News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

May 18, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, FDA, Novartis, Takeda, Trump, brexit, pharma, pharmafile, top ten

The year is flying by – it’s another Friday, and that means another Top Ten run-down.Perhaps the biggest story this …

News
ebola

Ebola threat intensifies in DR Congo

May 18, 2018
Medical Communications Ebola, MSD, biotech, drugs, pharma, pharmaceutical

The Ebola outbreak in the Democratic Republic of Congo is becoming increasingly serious, after it was confirmed that there was …

News

Pfizer’s Lyrica achieves endpoint as adjunct in paediatric epilepsy

May 18, 2018
Medical Communications, Research and Development FDA, Lyrica, Pfizer, epilepsy, pharma

Pfizer has revealed new Phase 3 data for its oral epilepsy therapy Lyrica (pregbalin) as an adjunctive treatment for partial …

News
headache

Amgen/Novartis potential blockbuster migraine med gets FDA nod

May 18, 2018
Medical Communications, Sales and Marketing Allergan, Amgen, Novartis, biotech, drugs, migraine, pharma, pharmaceutical

The first in a new class of migraine treatments has just received approval from the FDA; Amgen and Novartis’ Aimovig …

News

Study finds Herceptin use can be halved

May 17, 2018
Medical Communications, Research and Development Herceptin, Roche, biosimilars, biotech, drugs, pharma, pharmaceutical

A team of researchers from the University of Cambridge and Warwick Clinical Trials have revealed that Roche’s Herceptin is just …

News
ethan__drew_web

Living with an undiagnosed condition

May 17, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing feature, patient experience, pharma

Samantha O’Shea explains some of the challenges she faces caring for her son, Ethan, who lives with a debilitating but …

Feature
amgen_hq

Europe expands approved indication of Amgen’s Repatha in cardiovascular disease

May 17, 2018
Sales and Marketing Amgen, Repatha, cardiovascular disease, pharma

Amgen has revealed that its PCSK9 inhibitor Repatha (evolocumab) has received approval from the European Commission in a new indication: …

News

Ipsen receives European first-line approval for Cabometyx

May 17, 2018
Sales and Marketing Cabometyx, biotech, drugs, ipsen, pharma, pharmaceutical

Ipsen has revealed that it has received approval for the use of Cabometyx for first-line use in patients with advanced …

News
opioid_therapy_credit_-_us_air_force_valerie_monroy

FDA green lights first non-opioid therapy to manage symptoms of opioid withdrawal

May 17, 2018
Sales and Marketing FDA, Lucemyra, opioid crisis, opioids, pharma

As the opioid epidemic continues to grip the US as the leading cause of deaths in those under the age …

News
brexit_flag_0

UK MPs call for Brexit priority over pharma industry

May 17, 2018
Medical Communications ABPI, UK government, biotech, drugs, pharma, pharmaceutical

A new report published by the Business, Energy and Industrial Strategy Committee has called for the UK government to ensure …

News
roche_close

Roche gets NICE approval for advanced bladder cancer

May 17, 2018
Sales and Marketing Roche, biotech, drugs, pharma, pharmaceutical, tecentriq

Though trial results for Tecentriq (atezolizumab) may not necessarily be going Roche’s way, after a combination treatment failure, the treatment …

News
lilly_entrance_web

Lilly’s galcanezumab soars in episodic cluster headache, but fails in chronic form

May 16, 2018
Research and Development Eli Lilly, galcanezumab, headache, migraine, pharma

Eli Lilly has released new Phase 3 results for its CGRP inhibitor galcanezumab in the treatment of episodic cluster headache, …

News
novartis_side_building

Novartis’ top lawyer retires from role over botched Trump deal

May 16, 2018
Medical Communications, Research and Development Michael Cohen, Novartis, Trump, pharma

The saga of Novartis’ ill-advised $1.2 million deal with US President Donald Trump’s lawyer Michael Cohen continues to unfold as …

News

Pfizer scores approval for first Epogen/Procrit biosimilar in the US

May 16, 2018
Research and Development, Sales and Marketing Epogen, Pfizer, Procrit, Retacrit, biosimilar, pharma FDA

Pfizer’s Retacrit (epoetin alfa-epbx), a biosimilar version of Amgen’s Epogen and Janssen’s Procrit, has been approved for use in the …

News
cold

How to treat colds? Target the person, not the virus

May 15, 2018
Research and Development biotech, common cold, drugs, pharma, pharmaceutical

Researchers from Imperial College London have discovered how to interfere with one of the building blocks that allows the common …

News
dialogo

DIA: Pharmacovigilance conference

May 15, 2018
Medical Communications, Research and Development dia

We are in the midst of a breath-taking series of changes in the world of pharmacovigilance, both within Europe and …

News
shutterstock_159488225

New cancer clinical trial model promises to cut costs and development time

May 15, 2018
Manufacturing and Production, Research and Development BMS, Bristol-Myers Squibb, Cancer, MD AndersonCancer Center, clinical trials, pharma

Researchers from the University of Texas MD Anderson Cancer Center have been developing and testing a new model for the …

News
fda_building

FDA issues warning letter over potential for poisoning at India plant

May 15, 2018
Manufacturing and Production FDA, India, biotech, drugs, pharma, pharmaceutical

The FDA has noted a number of failings at a plant in Gujarat, India, but mostly significantly was the finding …

News
mosquito-49141_960_720

Smell test targets asymptomatic malaria carriers

May 15, 2018
Manufacturing and Production, Research and Development biotech, drugs, malaria, pharma, pharmaceutical

Asymptomatic carriers of malaria may be responsible for the onwards transmission of up to 90% of cases, highlighting the importance …

News
The Gateway to Local Adoption Series

Latest content

Historic UN declaration supporting mental health – treatment to be given similar priority to chronic diseases

January 30, 2026

Rare diseases – spinal muscular atrophy

January 30, 2026

Could targeting the molecular causes of infertility finally transform IVF success rates?

January 29, 2026

Digital mental health technologies – a valuable tool in supporting people with depression and anxiety

January 29, 2026

Barts Health NHS Trust collaborates with H.I.G. Realty on healthcare innovation building

January 29, 2026